Haroche J, Cohen-Aubart F, Amoura Z. Erdheim-Chester disease. Blood. 2020;135:1311–8.

PubMed  Google Scholar 

Goyal G, Heaney ML, Collin M, Cohen-Aubart F, Vaglio A, Durham BH, et al. Erdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular era. Blood. 2020;135:1929–45.

CAS  PubMed  Google Scholar 

Pegoraro F, Mazzariol M, Trambusti I, Bakhshi S, Mallick S, Dunkel IJ, et al. Childhood-onset Erdheim-Chester disease in the molecular era: clinical phenotypes and long-term outcomes of 21 patients. Blood. 2023;142:1167–71.

CAS  PubMed  PubMed Central  Google Scholar 

Pegoraro F, Papo M, Maniscalco V, Charlotte F, Haroche J, Vaglio A. Erdheim–Chester disease: a rapidly evolving disease model. Leukemia. 2020;34:2840–57.

CAS  PubMed  Google Scholar 

McClain KL, Bigenwald C, Collin M, Haroche J, Marsh RA, Merad M, et al. Histiocytic disorders. Nat Rev Disease Primers. 2021;7:73.

PubMed  Google Scholar 

Martínez-López J, Márquez A, Pegoraro F, Ortiz-Fernández L, Acosta-Herrera M, Kerick M, et al. Genome-wide association study identifies the first germline genetic variant associated with Erdheim-Chester disease. Arthritis Rheumatol. 2024;76:141–5.

PubMed  Google Scholar 

Mazzone R, Zwergel C, Artico M, Taurone S, Ralli M, Greco A, et al. The emerging role of epigenetics in human autoimmune disorders. Clin Epigenetics. 2019;11:34.

PubMed  PubMed Central  Google Scholar 

Esteller M, Dawson MA, Kadoch C, Rassool FV, Jones PA, Baylin SB. The epigenetic hallmarks of cancer. Cancer Discov. 2024;14:1783–809.

CAS  PubMed  Google Scholar 

Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov. 2022;12:31–46.

CAS  PubMed  Google Scholar 

Berdasco M, Esteller M. Clinical epigenetics: seizing opportunities for translation. Nat Rev Genetics. 2019;20:109–27.

CAS  PubMed  Google Scholar 

Ballestar E, Sawalha AH, Lu Q. Clinical value of DNA methylation markers in autoimmune rheumatic diseases. Nat Rev Rheumatol. 2020;16:514–24.

CAS  PubMed  PubMed Central  Google Scholar 

Tejedor JR, Bueno C, Vinyoles M, Petazzi P, Agraz-Doblas A, Cobo I, et al. Integrative methylome-transcriptome analysis unravels cancer cell vulnerabilities in infant MLLrearranged B cell acute lymphoblastic leukemia. J Clin Invest. 2021;131:e138833.

CAS  PubMed  PubMed Central  Google Scholar 

Barturen G, Babaei S, Català-Moll F, Martínez-Bueno M, Makowska Z, Martorell-Marugán J, et al. Integrative analysis reveals a molecular stratification of systemic autoimmune diseases. Arthritis Rheumatol. 2021;73:1073–85.

CAS  PubMed  Google Scholar 

Martínez-López J, Ortiz-Fernandez L, Estupiñán-Moreno E, Kerick M, Andrés-León E, Terron-Camero LC, et al. A strong dysregulated myeloid component in the epigenetic landscape of systemic sclerosis: an integrated DNA methylome and transcriptome analysis. Arthritis Rheumatol. 2024;77:439–49.

PubMed  PubMed Central  Google Scholar 

Go RS, Jacobsen E, Baiocchi R, Buhtoiarov I, Butler EB, Campbell PK, et al. Histiocytic neoplasms. J Natl Compr Cancer Netw. 2021;19:1277–303.

CAS  Google Scholar 

Barturen G, Beretta L, Cervera R, Van Vollenhoven R, Alarcón-Riquelme ME. Moving towards a molecular taxonomy of autoimmune rheumatic diseases. Nat Rev Rheumatol. 2018;14:75–93.

CAS  PubMed  Google Scholar 

Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43:e47.

PubMed  PubMed Central  Google Scholar 

Campos-Laborie FJ, Risueño A, Ortiz-Estévez M, Rosón-Burgo B, Droste C, Fontanillo C, et al. DECO: Decompose heterogeneous population cohorts for patient stratification and discovery of sample biomarkers using omic data profiling. Bioinformatics. 2019;35:3651–62.

CAS  PubMed  PubMed Central  Google Scholar 

Shabalin AA. Matrix eQTL: Ultra fast eQTL analysis via large matrix operations. Bioinformatics. 2012;28:1353–8.

CAS  PubMed  PubMed Central  Google Scholar 

Wishart DS, Feunang YD, Guo AC, Lo EJ, Marcu A, Grant JR, et al. DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 2018;46:D1074–82.

CAS  PubMed  Google Scholar 

Szklarczyk D, Franceschini A, Wyder S, Forslund K, Heller D, Huerta-Cepas J, et al. STRING v10: Protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 2015;43:D447–52.

CAS  PubMed  Google Scholar 

Karlsson M, Zhang C, Méar L, Zhong W, Digre A, Katona B, et al. A single–cell type transcriptomics map of human tissues. Sci Adv. 2021;7:eabh2169.

CAS  PubMed  PubMed Central  Google Scholar 

Bruno A, Noonan DM, Valli R, Porta G, Taramelli R, Mortara L, et al. Human RNASET2: a highly pleiotropic and evolutionary conserved tumor suppressor gene involved in the control of ovarian cancer pathogenesis. Int J Mol Sci. 2022;23:9074.

CAS  PubMed  PubMed Central  Google Scholar 

Wu C, Yang Y, Ou J, Zhu L, Zhao W, Cui J. LRRC14 attenuates Toll-like receptor-mediated NF-κB signaling through disruption of IKK complex. Exp Cell Res. 2016;347:65–73.

CAS  PubMed  Google Scholar 

de Streel G, Lucas S. Targeting immunosuppression by TGF-β1 for cancer immunotherapy. Biochem Pharmacol. 2021;192:114697.

PubMed  PubMed Central  Google Scholar 

Goyal G, Shah MV, Call TG, Litzow MR, Hogan WJ, Go RS. Clinical and radiologic responses to cladribine for the treatment of Erdheim-Chester disease. JAMA Oncol. 2017;3:1253–6.

PubMed  PubMed Central  Google Scholar 

Runkle KB, Kharbanda A, Stypulkowski E, Cao XJ, Wang W, Garcia BA, et al. Inhibition of DHHC20-mediated EGFR palmitoylation creates a dependence on EGFR signaling. Mol Cell. 2016;62:385–96.

CAS  PubMed  PubMed Central  Google Scholar 

Hawash M. Advances in cancer therapy: a comprehensive review of CDK and EGFR inhibitors. Cells. 2024;13:1656.

CAS  PubMed  PubMed Central  Google Scholar 

Takatsu K, Nakajima H. IL-5 and eosinophilia. Current Opinion in Immunology. 2008;20:288–94.

CAS  PubMed  Google Scholar 

Emslie D, Costa KD, Hasbold J, Metcalf D, Takatsu K, Hodgkin PO, et al. Oct2 enhances antibody-secreting cell differentiation through regulation of IL-5 receptor α chain expression on activated B cells. J Exp Med. 2008;205:409–21.

CAS  PubMed  PubMed Central  Google Scholar 

Hodson DJ, Shaffer AL, Xiao W, Wright GW, Schmitz R, Phelan JD, et al. Regulation of normal B-cell differentiation and malignant B-cell survival by OCT2. Proc Natl Acad Sci USA. 2016;113:E2039–46.

CAS  PubMed  PubMed Central  Google Scholar 

Liu F, Wu Q, Dong Z, Liu K. Integrins in cancer: emerging mechanisms and therapeutic opportunities. Pharmacol Ther. 2023;247:108458.

CAS  PubMed  Google Scholar 

Wang L, Hong W, Zhu H, He Q, Yang B, Wang J, et al. Macrophage senescence in health and diseases. Acta Pharm Sin B. 2024;14:1508–24.

CAS  PubMed  PubMed Central  Google Scholar 

Cangi MG, Biavasco R, Cavalli G, Grassini G, Dal-Cin E, Campochiaro C, et al. BRAFV600E-mutation is invariably present and associated to oncogene-induced senescence in Erdheim-Chester disease. Ann Rheum Dis. 2015;74:1596–602.

CAS  PubMed  Google Scholar 

Sun H, Li Y, Zhang P, Xing H, Zhao S, Song Y, et al. Targeting toll-like receptor 7/8 for immunotherapy: recent advances and prospectives. Biomark Res. 2022;10:89.

PubMed  PubMed Central  Google Scholar 

Shibata T, Sato R, Taoka M, Saitoh SI, Komine M, Yamaguchi K, et al. TLR7/8 stress response drives histiocytosis in SLC29A3 disorders. J Exp Med. 2023;220:e20230054.

CAS  PubMed  PubMed Central  Google Scholar 

Greulich W, Wagner M, Gaidt MM, Stafford C, Cheng Y, Linder A, et al. TLR8 is a sensor of RNase T2 degradation products. Cell. 2019;179:1264–75.e13.